Chan, Lap Sum https://orcid.org/0000-0003-3206-9064
Li, Gen
Fauman, Eric B. https://orcid.org/0000-0002-9739-0249
Yin, Xianyong https://orcid.org/0000-0001-6454-2384
Laakso, Markku https://orcid.org/0000-0002-3394-7749
Boehnke, Michael https://orcid.org/0000-0002-6442-7754
Song, Peter X. K. https://orcid.org/0000-0001-7881-7182
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Environmental Health Sciences (R01ES033656)
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (R01HG010731)
Academy of Finland (321428)
Article History
Received: 8 December 2022
Accepted: 25 May 2025
First Online: 1 July 2025
Competing interests
: E.B.F. is an employee and stockholder of Pfizer. The remaining authors declare no competing interests.